Preferred Label : guideline;

Obsolete resource : false;

CISMeF synonym : recommandation médicale;

Publication type (CISMeF) : true;

Details


Main resources

You can consult :


https://www.calameo.com/onco-occitanie/read/0071780926f9da30c68d6
2025
France
guideline
drug, nos
home care services, hospital-based
drug therapy
cancer
neoplasms
neoplasm, malignant

---
https://cps.ca/fr/documents/position/mise-a-jour-sur-linfection-congenitale-a-cytomegalovirus-la-prevention-prenatale-le-diagnostic-neonatal-et-la-prise-en-charge
2025
false
false
false
Canada
guideline
prenatal care
prenatal diagnosis
cytomegalovirus infections
infection control

---
https://www.cmg.fr/wp-content/uploads/2025/01/Accueil-et-prise-en-charge-des-personnes-en-situation-de-surpoids-ou-dobesite-CMG-20240425.pdf
2025
France
guideline
Obesity Management
overweight
obesity
obesity, nos
persons

---
https://www.sfed.org/wp-content/uploads/2025/01/SFED-Preparation-Coloscopie-adaptation-des-recommandations-de-lESGE-2019.pdf
2025
France
guideline
health planning guidelines
adaptation, nos
habilitation
colonoscopy
rehabilitation

---
https://www.has-sante.fr/jcms/p_3576094/fr/reprogrammation-au-bloc-operatoire-une-pratique-a-ne-pas-banaliser
2025
France
guideline
solution, nos
operating rooms
systolic pressure
tool, nos
solutions
professional practice
has patient
patient safety

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/protocole-medical-national-traitement-pharmacologique-visant-lelimination-fecale-chez-une-personne-qui-recoit-des-soins-palliatifs-ou-qui-presente-un-profil-geriatrique.html
2025
Canada
guideline
Geriatricians
geriatrics
pharmacology
palliative care, nos
persons
pharmacologist
feces
drug therapy
palliative care

---
https://www.reseau-naissance.fr/medias/2025/02/RSN-REF_007-Patho_neuromusc_anesth-obstetricale-MAJ-dec-2024-1.pdf
2025
France
guideline
neurology
muscular diseases
muscle, nos

---
https://ansm.sante.fr/actualites/vapotage-de-substances-psychoactives-hors-nicotine-des-pratiques-plus-risquees-quon-ne-le-pense
2025
false
false
false
France
French
Vaping
vigilance note
psychotropic drugs
risk
Synthetic cannabinoid (substance)
cannabinoids
adolescent
patient education handout
guideline

---
https://ansm.sante.fr/actualites/fortes-tensions-dapprovisionnement-en-quetiapine-xeroquel-lp-et-generiques-premieres-conduites-a-tenir
2025
false
false
false
France
French
guideline
drug information
Quetiapine Fumarate
quetiapine
Extemporaneous preparation (product)
drug compounding
Delayed-Action preparations
therapeutic equivalency
capsules
tablets
Immediate Release Capsule Dosage Form
Extended Release Tablet Dosage Form

---
https://www.cancer.fr/catalogue-des-publications/securisation-medicamenteuse-des-patients-traites-par-anticancereux-injectables-en-hopital-de-jour-d-oncologie-hematologie-referentiel-organisatio
https://www.cancer.fr/catalogue-des-publications/securisation-medicamenteuse-des-patients-traites-par-anticancereux-injectables-en-hopital-de-jour-d-oncologie-hematologie-synthese
2025
false
false
false
France
guideline
drug therapy
hospitals
administration of therapeutic substance, nos
antineoplastic agents
hematology
patients
day care center
hospital, nos
has patient
hospitalization
injections
Oncologists

---
https://www.cancer.fr/catalogue-des-publications/traitements-de-1re-ligne-du-cbnpc-metastatique-sans-addiction-oncogenique-synthese
https://www.cancer.fr/catalogue-des-publications/traitements-de-1re-ligne-du-cbnpc-metastatique-sans-addiction-oncogenique-thesaurus
2025
false
false
false
France
guideline
carcinoma, non-small-cell lung
behavior, addictive
oncogenes
oncogene
dependent drug abuse
fracture fixation
Cloud Computing

---
https://ansm.sante.fr/actualites/heparine-calcique-en-seringue-preremplie-tensions-dapprovisionnement-et-arret-de-commercialisation
2025
false
false
false
France
French
drug information
guideline
calcium heparin
injections, subcutaneous
Pre-filled Syringe
heparin
patients guideline
anticoagulants

---
https://ansm.sante.fr/actualites/paracetamol-attention-aux-intoxications-volontaires-par-des-enfants-et-des-adolescents
2025
false
false
false
France
French
adolescent
acetaminophen
Intentional paracetamol poisoning (disorder)
pharmacovigilance note
child
Chemical and Drug Induced Liver Injury
liver transplantation
Chemical and Drug Induced Liver Injury
france
patient education handout
guideline
paracetamol

---
https://www.has-sante.fr/jcms/p_3589971/fr/sam-de-l-ansm-sur-la-codeine-modification-des-conditions-de-prescription-et-de-delivrance-cpd-afin-de-reduire-le-risque-de-mesusage-d-addiction-et-de-surdosage
2025
false
false
false
France
drug prescriptions
guideline
codeine
substance-related disorders
Drug Misuse
prescription drug misuse
medical order entry systems
algorithms
risk management
codeine
drug overdose

---
https://www.cancer.fr/presse/renforcer-la-securisation-medicamenteuse-des-patients-sous-anticancereux-injectables
2025
France
guideline
antineoplastic agents
injections
patients
hospitalization
drug therapy
hospital, nos
day care center
has patient
hospitals
administration of therapeutic substance, nos

---
https://ansm.sante.fr/actualites/tramadol-et-codeine-les-nouvelles-regles-de-prescription-et-delivrance-entrent-en-vigueur-le-1er-mars-2025
2025
false
false
false
France
French
drug information
guideline
tramadol
codeine
legislation, pharmacy
drug prescriptions
popular works

---
https://www.has-sante.fr/jcms/p_3592850/fr/accompagner-des-le-premier-recours-pour-diminuer-le-risque-alcool-des-femmes
2025
France
guideline
alcohols
professional practice
effects of exposure to external cause, nos
alcohol, nos
tool, nos
alcoholism
risk
women
ethyl alcohol
cues
temefos
alcoholics
Exhibition
female

---
https://ansm.sante.fr/tableau-marr/isatuximab
2025
false
false
false
France
French
risk management
isatuximab
guideline
patient education handout
blood transfusion
indirect coombs test
Laboratory test interference

---
https://oncologik.fr/referentiels/sforl/generalites-referentiel-national-de-traitement-des-cancers-des-vads
2025
France
guideline

---
https://ansm.sante.fr/actualites/medicaments-a-base-de-methotrexate-par-voie-orale-imeth-novatrex-et-generiques-une-carte-patients-et-une-brochure-professionnels-de-sante-pour-eviter-les-surdosages
2025
false
false
false
France
French
risk management
risk
methotrexate
poisoning
pharmacovigilance note
guideline
patients guideline

---
https://www.sfmu.org/fr/vie-professionnelle/outils-professionnels/consensus//recommandations-relatives-aux-indications-de-l-utilisation-des-tests-quadriplex-virus-influenza-a-b-rsv-et-sars-cov-2-et-des-tests-multiplex-etendus-pour-le-diagnostic-des-viroses-respiratoires-dans-le-contexte-hospitalier-et-etablissement-de-soins/con_id/561
2025
France
guideline
hospital, nos
Off-Label use
virus diseases
indication of
nursing
viruses
suggestive of
diagnosis
hospitals
site of care, nos
influenza A virus
influenzavirus, nos
no diagnosis
SARS-CoV-2

---
https://ansm.sante.fr/actualites/aggravation-des-tensions-en-pegasys-nouvelles-mesures-et-referentiel-actualise
2025
false
false
false
France
French
peginterferon alfa-2a
drug information
Ropeginterferon Alfa-2B
guideline
popular works

---
https://ansm.sante.fr/actualites/tensions-dapprovisionnement-en-rythmodan-250-mg-lp-disopyramide-recommandations-pour-les-pharmaciens-et-les-medecins
2025
false
false
false
France
French
drug information
popular works
guideline
disopyramide
Disopyramide Phosphate
Delayed-Action preparations
disopyramide
anti-arrhythmia agents

---
https://www.has-sante.fr/jcms/c_2626164/fr/evaluation-des-infrastructures-de-simulation-en-sante
2025
France
guideline
evaluation studies as topic
tool, nos
malingering
black fly, nos
health
professional practice
health personnel

---
https://www.reseau-naissance.fr/medias/2025/03/RSN_PRO_022-depsitage-cardiopathie-sat-mater.pdf
2025
France
guideline
weights and measures
oximetry, pulse
motherhood
heart defects, congenital
hospitals, maternity
congenital abnormalities
developmental anomaly, nos
mass screening
screening
pulse, nos
oxygen analyzer
heart, nos
oximetry
measures

---
https://www.reseau-naissance.fr/medias/2025/03/RSN-REF_012-Vaccination_nne-a-terme-et-prema.pdf
2025
France
guideline
infant, newborn
vaccination
infant, premature
vaccination, nos
premature birth of newborn, nos
vaccination
premature newborn
preventive immunization/medication

---
https://ansm.sante.fr/actualites/tensions-dapprovisionnement-en-sertraline-mesures-et-recommandations-pour-assurer-la-continuite-des-traitements
2025
false
false
false
France
French
sertraline
antidepressive agents
sertraline
drug information
Selective Serotonin Reuptake Inhibitors
guideline
continuity of patient care

---
https://www.ccne-ethique.fr/fr/publications/avis-149-du-ccne-sur-la-baisse-de-la-natalite-et-de-la-fertilite
2025
France
guideline
fertility, nos
fertility
population growth
judgment

---
https://www.cosprc.ca/fr/enonce-de-position-conjoint-sur-la-technologie-au-plasma-pour-realiser-une-blepharoplastie-et-le-role-joue-par-les-medias-sociaux-dans-les-interventions-esthetiques/
2025
Canada
guideline
technology
achievement
spouses
role
blepharoplasty
social media
cheek
esthetics
plasma
blepharoplasty, nos

---
https://www.has-sante.fr/jcms/p_3599791/fr/label-flash-securite-patient-neuroleptiques-a-action-prolongee-nap-les-nap-parfois-ca-derape
2025
France
guideline
professional practice
tool, nos
antipsychotic agents
has patient
patient safety
id
long

---
https://ansm.sante.fr/informations-de-securite/kisqali-ribociclib-changement-des-conditions-de-conservation-et-de-la-duree-de-conservation
2025
false
false
false
France
French
drug information
guideline
drug storage
ribociclib

---
https://ansm.sante.fr/informations-de-securite/opzelura-15-mg-g-creme-phosphate-de-ruxolitinib-information-importante-concernant-la-presence-de-particules
2025
false
false
false
France
French
pharmacovigilance note
ruxolitinib
administration, cutaneous
ruxolitinib
guideline

---
https://www.reseau-naissance.fr/medias/2025/04/RSN-REF_005-Cannabis-et-grossesse.pdf
2025
France
guideline
pregnancy
cannabis, nos
pregnancy, nos
cannabis

---
https://publications.msss.gouv.qc.ca/msss/document-002135/
2025
Canada
algorithms
guideline
neonatal screening, nos
patient care management
cystic fibrosis
cystic fibrosis
fibrosis
neonatal screening

---
https://sfar.org/reflexions-et-conclusions-du-copp-apres-etude-de-la-litterature-et-des-recommandations-dans-differents-pays-sur-la-sortie-sans-accompagnant-apres-chirurgie-ambulatoire/?utm_source=rss&utm_medium=rss&utm_campaign=reflexions-et-conclusions-du-copp-apres-etude-de-la-litterature-et-des-recommandations-dans-differents-pays-sur-la-sortie-sans-accompagnant-apres-chirurgie-ambulatoire
2025
France
guideline
reflex
ambulatory surgical procedures
exit
reflex, nos
thinking
health planning guidelines
data collection
operative procedure, nos
literature

---
https://cps.ca/fr/documents/position/preparations-magistrales-formulations
2025
Canada
guideline
pediatrician
government
Pediatricians
pediatrics
naming, nos
canada

---
https://www.has-sante.fr/jcms/p_3603861/fr/flash-securite-patient-rupture-de-stock-de-produit-de-sante-ne-rompez-pas-le-contact
2025
guideline
professional practice
rupture
laceration, nos
patient safety
equipment and supplies
has patient
health
tool, nos

---
https://ansm.sante.fr/documents/reference/bonnes-pratiques-de-collecte-de-selles
2025
false
false
false
France
French
guideline
feces

---
https://ansm.sante.fr/actualites/confusion-air-oxygene-nous-recommandons-de-retirer-les-debitmetres-dair-apres-chaque-utilisation
2025
false
false
false
France
French
guideline

---
https://ansm.sante.fr/informations-de-securite/veoza-fezolinetant-risque-de-lesion-hepatique-et-nouvelles-recommandations-concernant-la-surveillance-de-la-fonction-hepatique-avant-et-pendant-le-traitement
2025
false
false
false
France
French
pharmacovigilance note
fezolinetant
Chemical and Drug Induced Liver Injury
fezolinetant
continuity of patient care
guideline
Monitoring of liver function (regime/therapy)

---
https://ansm.sante.fr/actualites/tensions-en-sertraline-zoloft-et-generiques-lansm-accompagne-la-mise-a-disposition-de-preparations-magistrales
2025
false
false
false
France
French
sertraline
drug information
guideline
drug compounding
Extemporaneous preparation (product)
popular works

---
https://ansm.sante.fr/actualites/tensions-dapprovisionnement-en-teralithe-lp-400-mg-sel-de-lithium-recommandations-pour-assurer-la-continuite-des-traitements
2025
false
false
false
France
French
drug information
lithium carbonate
Delayed-Action preparations
administration, oral
guideline
continuity of patient care
lithium
lithiemia
Lithium blood measurement (procedure)

---
https://ansm.sante.fr/actualites/lansm-publie-un-guide-reglementaire-pour-les-fabricants-de-protheses-oculaires
2025
false
false
false
France
French
guideline
legislation, pharmacy
eye, artificial
Ocularist
france

---
https://www.has-sante.fr/jcms/p_3602950/fr/evenements-indesirables-graves-associes-aux-soins-eigs-survenus-chez-les-nouveau-nes
2025
France
guideline
nursing
infant, newborn
tool, nos
newborn, nos
professional practice

---
https://www.omedit-centre.fr/medias/Prise-en-charge_Carence-martiale.pdf
2025
France
guideline
patient care management
iron deficiency, nos
Iron Deficiencies

---
https://www.reseau-naissance.fr/medias/2016/12/RSN-REF_016-Recommandations-soins-palliatifs-nouveau-nes-maternite.pdf
2025
France
guideline
neonatal nursing
newborn, nos
hospitals, maternity
palliative care, nos
motherhood
palliative care
infant, newborn

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/usage-optimal-des-immunoglobulines.html
2025
false
false
false
false
false
Canada
guideline
technical report
immunoglobulins

---
https://ansm.sante.fr/tableau-marr/zilucoplan
2025
false
false
false
France
French
risk management
guidelines for drug use
patients guideline
injections, subcutaneous
zilucoplan
Drug-Related side effects and adverse reactions
zilucoplan
complement inactivating agents
vaccination
meningococcal infections
meningococcal vaccines
guideline

---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-disponibilite-de-tsoludose-solution-buvable-en-recipient-unidose
2025
false
false
false
France
French
drug information
thyroxine
levothyroxine sodium
administration, oral
pharmaceutical solutions
patients guideline
guideline

---
https://ansm.sante.fr/dossiers-thematiques/plan-hivernal
2025
false
false
false
France
French
guideline
anti-bacterial agents
glucocorticoids
anti-asthmatic agents
continuity of patient care
break in supply
Drug Shortage
antipyretics
Product supply issue
drug information

---
https://ansm.sante.fr/actualites/difficultes-dapprovisionnement-en-methylphenidate-lansm-publie-des-recommandations-pour-les-pharmaciens
2025
false
false
false
France
French
drug information
guideline
methylphenidate
methylphenidate
patient education handout
administration, oral
drug substitution

---
https://ansm.sante.fr/tableau-marr/fentanyl-8
2025
false
false
false
France
French
fentanyl
patients guideline
guidelines for drug use
risk management
video recording
guideline
fentanyl

---
https://ansm.sante.fr/tableau-marr/lomitapide
2025
false
false
false
France
French
risk management
lomitapide
lomitapide
patient education handout
guideline
drug interactions
anticholesteremic agents
lomitapide
anticholesteremic agents
administration, oral

---
https://ansm.sante.fr/tableau-marr/eladocagene-exuparvovec
2025
false
false
false
France
French
risk management
guidelines for drug use
Eladocagene Exuparvovec
drug compounding
Stereotactic surgery
stereotaxic techniques
gene therapy
Intraputaminal Route of Administration
aromatic amino acid decarboxylase deficiency
Injection of brain (procedure)
infusions, parenteral
neurosurgical procedures
patient education handout
guideline
eladocagene exuparvovec

---
https://www.has-sante.fr/jcms/p_3367704/fr/le-patient-en-auto-administration-de-ses-medicaments-en-cours-d-hospitalisation
2025
false
false
false
France
guideline
has patient
Methodology
self administration
Methodology
administration of medication, nos
pharmaceutical preparations
inpatients
administration
Methodology
methods
Handbook
hospital admission, nos
Administration

---
https://ansm.sante.fr/documents/reference/la-pharmacopee-francaise
2025
false
false
false
France
French
Pharmacopoeia
guideline
france

---
https://www.sfed.org/wp-content/uploads/2025/01/SFED-Recommandations-Preparation-Coloscopie-adaptation-des-recommandations-de-lESGE-2019.pdf
2025
France
guideline
health planning guidelines
adaptation, nos
colonoscopy
rehabilitation
habilitation

---
https://www.inspq.qc.ca/publications/3462
2024
Canada
guideline
retirement, nos
steam
Medical Device
Device Usage
retirement
Reprocess
medical devices
equipment and supplies
device, nos
Vapor
steam

---
https://www.has-sante.fr/jcms/p_3498889/fr/enquete-de-perception-de-l-accreditation-des-medecins-et-des-equipes-medicales
2024
false
false
false
France
guideline
Tool
Survey
Improved
Enhance
perception
Investigation
equipment
data collection
detective
tool, nos
equipment and supplies
Perception
physicians
professional practice
accreditation
perception, nos
Medication
Inquiry
Professional Practice
Scientific Equipment

---
https://ansm.sante.fr/actualites/faux-negatifs-de-rai-de-depistage-i-mag-screen-diagast-des-recommandations-entrent-en-application
https://ansm.sante.fr/informations-de-securite/immuno-hematologie-reactif-i-mag-screen-diagast-1
2024
false
false
false
France
French
hemovigilance
guideline
screening of irregular agglutinins
false negative reactions
vigilance note

---
https://conseil-scientifique.public.lu/fr/publications/perinat/prise-en-charge-medicale-du-desir-d-enfant-et-traitement-de-l-infertilite-pma-2024.html
https://conseil-scientifique.public.lu/fr/publications/perinat/prise-en-charge-medicale-du-desir-d-enfant-et-traitement-de-l-infertilite-pma-arbre-decisionnel-2024.html
2024
Luxembourg
guideline
Medically Treated Reflux
Child Relation
Charge
NCKIPSD wt Allele
child, nos
Child Individual
Premarket Device Application
infertility
infertility, nos
reproductive techniques, assisted
NCK-Interacting Protein with SH3 Domain
Tetradecanoylphorbol Acetate
4-methoxyamphetamine
patient care management
child
Infertility

---
https://publications.msss.gouv.qc.ca/msss/document-003699/
2024
Canada
guideline
Integrator Device
Guide Device
wellness state
Integrated
practice guidelines as topic
Nearest
mental health
Near
practice guideline
Mental Health
Healthy
Best Practice

---
https://www.has-sante.fr/jcms/p_3423859/fr/reflux-gastro-oesophagien-chez-l-enfant-de-moins-d-un-an-definitions-prise-en-charge-et-pertinence-des-traitements-pharmacologiques
2024
France
guideline
Improved
patient care management
pharmacology
Scientific Equipment
child, nos
Child Individual
pharmacologist
Definitive
Tool
child
Child Relation
Enhance
tool, nos
gastroesophageal reflux
Perflutren Lipid Microspheres
Professional Practice
professional practice
Pharmacotherapy
Gastroesophageal Reflux
gastroesophageal reflux
Adverse Event Definitely Related to Intervention
Charge
drug therapy

---
https://www.has-sante.fr/jcms/p_3501842/fr/entretien-motivationnel
2024
France
guideline
Tool
Enhance
Motivational Interviewing
professional practice
Scientific Equipment
motivational interviewing
Improved
tool, nos
Professional Practice

---
https://www.has-sante.fr/jcms/p_3501843/fr/intervention-motivationnelle-breve
2024
France
guideline
Bleomycin/Cisplatin/Doxorubicin/Etoposide
Professional Practice
Tool
Scientific Equipment
Brief
EBAP Regimen
Intervention
early medical intervention
tool, nos
professional practice
Enhance
Intervention for Congenital Heart Disease
pitta, nos
Improved

---
https://www.rp2s.fr/wp-content/uploads/2024_HepB_18mars.pdf
2024
France
guideline
Unknown Site of New Tumor Event
Not Known if Peripheral Blood Immunophenotyping and Cytochemistry Were Performed
Unknown if Medication Taken
Adjuvant Post-operative Targeted Molecular Therapy Administration Unknown
1p/19q Codeletion Status Unknown
Not Known if NF1 Mutation Analysis Was Performed
Tumor Reoccurrence Unknown After Initial Treatment
Unknown History of Kawasaki Disease
Unknown Daily Fluid Intake
Unknown if Subsequent Known Primary Melanoma(s) Found During the Follow-Up
Not Known if EGFR Amplification Analysis Was Performed
Cancer History Unknown
Not Known if MGMT Promoter Methylation Testing Was Performed
Evidence of Disease Unknown after Completion of Therapy
Unknown History of Congenital Heart Disease
Average Daily Use Smokeless Tobacco after Use for Six Weeks Unknown
hepatitis surface antigen
Not Known if SDH Complex Mutation Analysis Was Performed
Hypertension Unknown
Stage Unknown
First Course Treatment Completion Measure of Success of Outcome Unknown
Unknown History of Alcohol Use
Not Known if KRAS Mutation Analysis Was Performed
Not Known if PDGFRA Mutation Analysis Was Performed
Unknown if Chemotherapy Was Administered as an Additional Treatment for a New Tumor Event
Not Known if Fluorescence In Situ Hybridization Was Performed
Multiple Known Primary Tumors Unknown at Initial Melanoma Diagnosis
Unknown History of Gestational Complication
Not Known if MET Mutation Analysis Was Performed
Not Known if ALK Rearrangement Analysis Was Performed
surrogate mother
Not Known if 1p/19q Deletion Analysis Was Performed
Unknown Daily Salt Intake
Unknown History of Non-Cardiac Surgery
Not Known if Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Performed
Not Known if BRAF Mutation Analysis Was Performed
Tumor Progression Unknown After Initial Treatment
Sex Not Known
hepatitis B
Performance Status Scale Timing Unknown
Unknown if Chief Complaint was Witnessed
Not Known if BRAF Rearrangement Analysis Was Performed
Not Known if RET Rearrangement Analysis Was Performed
Unknown if Immunotherapy Was Administered as an Additional Treatment for a New Tumor Event
History of Medical Treatment Unknown
Unknown Age When Started using Smokeless Tobacco after Regular Use
Adjuvant Post-operative Pharmaceutical Therapy Administration Unknown
Use of Smokeless Tobacco at Time of Diagnosis Unknown
Unknown GENC
Unknown Tamoxifen Use
New Tumor Event After Initial Treatment Unknown
Charge
Additional Surgery for New Tumor Event Unknown
Unknown Oral Contraceptive Use
birth, nos
Unknown if Chief Complaint Caused by Trauma
Unknown when Chief Complaint Present
Unknown History of Neonatal Complication
Not Known if Additional Molecular Studies Were Performed
Device Status Unknown
Adjuvant Post-operative Radiation Therapy Administration Unknown
parturition
Unknown if Patient Has Genetic Syndrome Associated with Congenital Heart Defect
Unknown if Targeted Molecular Therapy Was Administered as an Additional Treatment for a New Tumor Event
Not Known if PTEN Mutation Analysis Was Performed
Unknown Procedure Type for New Tumor Event
Not Known if 10q23/PTEN Locus Deletion Analysis Was Performed
Adjuvant Post-operative Immunological Therapy Administration Unknown
Unknown History of Illicit Drug Use
Unknown if Routine Cytogenetics were Completed
Unknown Clark Level
Immunotherapy Status Unknown
hepatitis B surface antigens
Unknown Family History Cardiovascular Disease or Cardiovascular Disease Risk Factors
Regular Smokeless Tobacco Use for Six Weeks or More Unknown
Unknown Transformation
Additional Surgery for New Loco-Regional Tumor Event Unknown
Unknown History of Rheumatic Fever
Unknown if Interferon Gamma Treatment was Administered Prior to Specimen Resection
Chemotherapy Status Unknown
Unknown Use of Menopausal Hormone Therapy
Chemical/Occupational Exposure Type Unknown
Unknown Number of Full Term Pregnancies
Unknown if Another form of Birth Control was Used
Not Known if IDH Family Mutation Analysis Was Performed
Chemical/Occupational Exposure History Unknown
Not Known if Lymph Node Dissection Was Performed
Unknown Molecular Analysis
Not Known if EGFR Mutation Analysis Was Performed
Molecular Abnormalities Unknown
Unknown if Caffeine Consumption is Routine
Gestational Carriers
Not Known if NRAS Mutation Analysis Was Performed
patient care management
Not Known if ROS1 Rearrangement Analysis Was Performed
Unknown if Hormone Therapy Was Administered as an Additional Treatment for a New Tumor Event
Unknown History of Myopathy
Unknown Release Mechanism of Action
Unknown Daily Caloric Intake
Not Known if KIT Mutation Analysis Was Performed
Tumor Location Unknown
type b viral hepatitis
Adjuvant Post-operative Chemotherapy Administration Unknown
Documentation Unknown
Unknown if New Disease is Multifocal
Additional Surgery for New Metastatic Tumor Event Unknown
Unknown Dosage Form Category
Physician Diagnosed Diabetes Unknown
Hepatitis B Infection
Birth Time
Unknown Route of Administration
Follow-Up Form Completion Outcome Measure of Success Unknown
Paraneoplastic Syndrome Status is Unknown
Tumor Laterality Unknown
Not Known if Additional Immunohistochemistry Was Performed
Unknown if Radiation Was Administered as an Additional Treatment for a New Tumor Event
Intercurrent Illness is Unknown at Onset of Chief Complaint
Not Known if TP53 Mutation Analysis Was Performed
Unknown History of Other Muscular Dystrophy or Glycogen Storage Disorder
Not Known if ERBB2 Mutation Analysis Was Performed
Unknown if Patient was Previously Evaluated for Current Chief Complaint
Birth Month
Not Known if ATRX Mutation Analysis Was Performed
Interferon Gamma Treatment Administration 90 Days Prior to Specimen Resection Unknown

---
https://www.rp2s.fr/wp-content/uploads/2024_Infection-uterine_mars.pdf
2024
France
guideline
congenital infectious disease, nos
Endometritis
Intrauterine

---
https://www.has-sante.fr/jcms/p_3502633/fr/flash-securite-patient-transport-intrahospitalier-des-patients-de-soins-critiques-le-transport-lui-aussi-est-critique
2024
France
guideline
tool, nos
professional practice
transportation of patients
Patient Navigation
Safety
Improved
Tool
Professional Practice
Safety Study
patient transfer
evaluation studies as topic
Enhance
CASP8AP2 wt Allele
carrying
patient safety
Veterinary Patient
patient care
has patient
Scientific Equipment
critical care

---
https://www.msss.gouv.qc.ca/professionnels/soins-et-services/protocoles-paramedics-soins-primaires/
2024
Canada
guideline
Clinical Study Protocol
allied health personnel
On Study
principal
Clinical Lot
Clinical Batch
Paramedic
primary health care
Ambulatory Care Facility
nursing
primary health care
Clinical Data
clinical protocols
Intervention for Congenital Heart Disease
Intervention
Primary Care
Usage

---
https://static.cnsf.asso.fr/wp-content/uploads/2024/02/Guide-Pratique-EPNP_V3.pdf
2024
France
guideline
interview
midwifery
attention
Handbook
Warning
interviews as topic
Guide Device
Reviewing
midwives
attention, nos
Woman
Maintenance Clinical Trial Setting
Medication
System Alert
Splayed
physicians, women

---
https://sfar.org/gestion-de-lanticoagulation-dans-un-contexte-durgence/
2024
France
guideline
algorithms
anticoagulants
Application Context
emergencies
anticoagulant, nos
Anticoagulant Agent
Contingency Management

---
https://sfar.org/optimisation-hemodynamique-perioperatoire-adulte-dont-obstetrique/
2024
France
guideline
Optimization
obstetrics
hemodynamics
Perioperative
Observational Study Sampling Method

---
https://sfar.org/optimisation-hemodynamique-perioperatoire-pediatrie/
2024
France
guideline
Perioperative
pediatrics
hemodynamics
Pediatric
pediatrician
Optimization
Pediatric

---
https://www.has-sante.fr/jcms/p_3505883/fr/bonnes-pratiques-en-matiere-de-simulation-en-sante
2024
false
false
false
France
Simulation Training
computer simulation
computer simulation
guideline

---
https://www.has-sante.fr/jcms/p_3240311/fr/flash-securite-patient
2024
France
guideline
Improved
Safety
patient safety
Professional Practice
tool, nos
Veterinary Patient
professional practice
occupational health
has patient
Enhance
Tool
Scientific Equipment
CASP8AP2 wt Allele
Safety Study

---
https://sante.gouv.fr/IMG/pdf/dgs-urgent-no2024_04_reply.pdf
https://sante.gouv.fr/IMG/pdf/202404_dgs-urgent-rougeole_vf_-_mise_en_ligne.pdf
2024
false
false
false
France
French
measles
france
europe
vigilance note
mandatory reporting
disease notification
guideline
measles
vaccination
Post-Exposure prophylaxis
measles
signs and symptoms

---
https://www.has-sante.fr/jcms/p_3502487/fr/flash-securite-patient-canicule-personnes-hospitalisees-et-hebergees-en-etablissement-medico-social-mettez-les-patients-au-frais-avant-qu-ils-n-en-fassent-les-frais
2024
France
guideline
strawberry
Recovered from Adverse Event
Inpatient Encounter
Healthcare Facility
Blackberry
Strawberry Flavor
Enhance
Safety Study
CASP8AP2 wt Allele
has patient
Tool
patient safety
tool, nos
residential facilities
Professional Practice
Institution
extreme heat
Strawberry
housing
Blackberry Flavor
professional practice
inpatients
fees and charges
socialism
persons
Improved
charges
Safety
Scientific Equipment
Social
hospital admission, nos
Inpatient

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/pertinence-des-consultations-et-tests-preoperatoires-pour-une-chirurgie-elective-a-faible-risque-chez-les-personnes-de-16-ans-et-plus.html
2024
Canada
guideline
Consultation
International Prognostic Index Low Risk Group
Disease Risk Index Low Risk
IPSS-R Risk Category Low
Low Risk
operative procedure, nos
Autonomic Nervous System
Elective Surgical Procedures
Sixteen
Elective Surgical Procedure
asthenia
Drug Accumulation 1.2 to 1.99
American Samoa
American College of Cardiology/American Heart Association Lesion Complexity Score A
persons
People
More
Human Papillomavirus-16
referral and consultation
Laboratory Procedure
consultants
risk

---
https://www.reseau-naissance.fr/medias/2024/04/CMV-guide-pratique-pour-le-praticienVdef.pdf
2024
France
guideline
Guide Device
Cytomegalovirus
physicians
Cyclophosphamide/Etoposide/Methotrexate
cytomegalovirus
Handbook
MCV Regimen
Splayed

---
https://conseil-scientifique.public.lu/fr/publications/examens-laboratoire/osteoporose-2023.html
2024
Luxembourg
guideline
osteoporosis
Diagnosis Study
Fracture
osteoporosis
diagnosis
osteoporosis, nos
Diagnosis Code
risk assessment
fracture, nos
Charge
Fracture of Device/Material
osteoporotic fractures
no diagnosis
CDISC SDTM Protocol Risk Assessment Response Codelist
patient care management
Date of Diagnosis
Osteoporosis
Health Risk Assessment
risk-taking

---
https://www.reseau-naissance.fr/medias/2016/12/Protocole-PEC-nne-de-mere-sous-opiaces-pendant-la-grossesse.pdf
2024
France
guideline
opioid withdrawal
newborn, nos
New Lesion Identification
Newar Language
infant, newborn
health planning guidelines
charge association
CHARGE Syndrome
mother, nos
Maternal
Maternal Relative
patient care management
CHARGE syndrome
substance withdrawal syndrome
Opiate Withdrawal Syndrome

---
https://ansm.sante.fr/tableau-marr/darvadstrocel
2024
false
false
false
France
French
risk management
Darvadstrocel
darvadstrocel
guidelines for drug use
guideline
medication errors
Darvadstrocel
drug storage
Infections
cold chain
temperature recording

---
https://ansm.sante.fr/actualites/flecainide-a-liberation-prolongee-conduite-a-tenir-dans-un-contexte-de-tensions-dapprovisionnement
2024
false
false
false
France
French
guideline
Delayed-Action preparations
flecainide
administration, oral
Flecainide Acetate
flecainide

---
https://ansm.sante.fr/actualites/tensions-dapprovisionnement-en-corgard-80-mg-nadolol-ce-medicament-doit-etre-reserve-a-certains-patients-atteints-de-troubles-du-rythme-dorigine-genetique
2024
false
false
false
France
French
nadolol
drug information
guideline
patient education handout
Genetic cardiac rhythm disease
arrhythmias, cardiac
nadolol
arrhythmias, cardiac

---
https://ansm.sante.fr/tableau-acces-derogatoire/adcetris-50-mg-poudre-pour-solution-a-diluer-pour-perfusion
2024
false
false
false
France
French
continuity of patient care
guideline
hodgkin disease
child
adolescent
adult
antineoplastic combined chemotherapy protocols
brentuximab vedotin
Brentuximab Vedotin
infusions, intravenous

---
https://publications.msss.gouv.qc.ca/msss/document-003513/
2024
false
false
false
Canada
guideline
Practice

---
https://www.calameo.com/onco-occitanie/read/007178092951d790c9115
2024
false
false
false
France
guideline
Myeloma
multiple myeloma
Myeloma

---
https://www.has-sante.fr/jcms/p_3218057/fr/parcours-de-sante-d-une-personne-presentant-une-douleur-chronique
2024
false
false
false
France
france
continuity of patient care
health services accessibility
acute pain
chronic pain
chronic pain
guideline
chronic pain
chronic pain

---
https://www.has-sante.fr/jcms/p_3237041/fr/symptomes-prolonges-suite-a-une-covid-19-de-l-adulte-diagnostic-et-prise-en-charge
2024
false
false
false
France
pneumonia, viral
coronavirus infections
signs and symptoms
rehabilitation
guideline
patient care management
adult
pandemics
pneumonia, viral
coronavirus infections
pandemics
pneumonia, viral
coronavirus infections
pandemics
pneumonia, viral
coronavirus infections
pandemics
COVID-19
COVID-19
COVID-19

---
http://www.orpha.net/data/patho/Emg/Int/fr/Mastocytoses_FR_fr_EMG_ORPHA98292.pdf
2024
false
false
false
France
emergency medical services
risk
emergencies
angioedema
anaphylaxis
abdominal pain
diarrhea
hemorrhage
Bone Pain
anesthesia
Drug-Related side effects and adverse reactions
guideline
mastocytosis
emergency medicine

---
https://cps.ca/fr/documents/position/les-blessures-par-piqure-daiguille-dans-un-lieu-public
2024
false
false
Canada
French
blood-borne pathogens
needlestick injuries
child
hepatitis b virus
hepatitis B
risk
chemoprevention
hepacivirus
hepatitis C
HIV
hiv infections
guideline
journal article

---
https://canadiantaskforce.ca/lignesdirectrives/lignes-directrices-publiees/deficience-cognitive/?lang=fr
2024
false
false
false
false
Canada
French
guideline
french abstract
cognition
disturbance in cognition

---
https://cps.ca/fr/documents/position/la-prevention-et-le-controle-des-infections-au-cabinet-du-pediatre
2024
false
false
false
Canada
guideline
Infectious disease
pediatrics
infection control
infectious disease, nos
Pediatricians
pediatrician
Infections
Infections

---
https://cps.ca/fr/documents/position/des-infections-osteoarticulaires-aigues-chez-les-enfants
2024
false
false
false
Canada
bone diseases, infectious
bone diseases, infectious
arthritis, infectious
arthritis, infectious
diagnosis, differential
acute disease
guideline
child
patient care management

---
https://ansm.sante.fr/tableau-marr/insuline-degludec
2024
false
false
false
France
French
risk management
insulin degludec
medication errors
guidelines for drug use
injections, subcutaneous
insulin degludec
patient education handout
hypoglycemic agents
guideline
insulin, long-acting

---
https://ansm.sante.fr/tableau-marr/levonorgestrel-diu
2024
false
false
false
France
French
administration, intravaginal
levonorgestrel
risk management
patient education handout
intrauterine devices, medicated
plastic iud with progestogen
pregnancy, ectopic
risk
guideline
Insertion of intrauterine contraceptive device (procedure)
Contraceptive Effectiveness

---
https://ansm.sante.fr/tableau-marr/sonidegib
2024
false
false
false
France
French
risk management
sonidegib
teratogens
pregnancy
abnormalities, drug-induced
contraception
pregnancy tests
antineoplastic agents
fetal death
patient education handout
guidelines for drug use
guideline
sonidegib
biphenyl compounds
pyridines

---
https://ansm.sante.fr/tableau-marr/thalidomide
2024
false
false
false
France
French
risk management
thalidomide
teratogens
abnormalities, drug-induced
pregnancy
thalidomide
guideline
forms
patient education handout
continuity of patient care
Neuropathy peripheral
thromboembolism
Drug-Related side effects and adverse reactions
pregnancy tests
contraception
package leaflet

---
https://ansm.sante.fr/tableau-marr/valproate-et-derives
2024
false
false
false
France
French
risk management
valproate
pregnancy
teratogens
valproate sodium
-
Divalproex Sodium
dipropylacetamide
pregnancy tests
contraception
guideline
patient education handout
forms
developmental disabilities
Contraindications, Drug
valproic acid
valproic acid

---
https://sfsep.org/sep-et-vaccinations/
2024
true
false
false
false
France
guidelines as topic
professional practice
patient care management
drug interactions
Immunosuppression Therapy
guideline
multiple sclerosis
multiple sclerosis
multiple sclerosis, nos
vaccination, nos
preventive immunization/medication
vaccination
Multiple sclerosis
multiple sclerosis

---
https://www.has-sante.fr/jcms/p_3511526/fr/flash-securite-patient-surveillance-des-patients-en-service-de-soins-critiques-une-veille-sans-faille-pour-qu-aucun-patient-ne-defaille
2024
France
guideline
Risk Factor History Negative
Null
Drug Accumulation Less than 1.2
None Device
Desmosine
critical care
patient care
CASP8AP2 wt Allele
No Hand Mobility
Patient Care
Use_For
No Support Needed
patients
patient safety
Non-Neoplastic Finding Absent
No Exacerbating Factor to Chief Complaint
custodial care
WWOX wt Allele
Safety Monitoring
No Signs and Symptoms Associated with Chief Complaint
professional practice
Care Of
Professional Practice
No Alleviating Factor to Chief Complaint
failure, nos
USH1G wt Allele
Patient Monitoring
Patient
No Effort
Human Papillomavirus Negative
has patient

---
https://www.has-sante.fr/jcms/p_3516905/fr/sam-de-la-cnam-sur-les-inhibiteurs-de-la-pompe-a-protons-ipp-bon-usage-chez-l-enfant-de-moins-de-1-an
2024
France
guideline
Reference
proton
Proton Pump Inhibitor
Decision Aid
CDISC SDTM Model Version 1.5
Usage
Phase I Trial
Concomitant Agent
Device System
proton-pump inhibitors
Bisphosphonate-Associated Osteonecrosis
operations research
Genetic Reference Sequence
Medicinal Product
Clinical Status Ordinal Scale Outcome 1
Drug Delivery System
ECOG Performance Status 1
proton pump inhibitors
Fear Score 1
Drug Delivery System Category
Sequence Alignment Map
Upset Score 1
Illness Intrusiveness Rating 1
Severity of Symptom Score 1
Neck Pain Score 1
mosaic variegated aneuploidy syndrome
Gleason Grade Group 1
Agreement Score 1
Intensity and Distress 1
Mild Adverse Event
child
One Hundred Percent
pharmaceutical preparations
Tumor Regression Score 1
One Full Term Pregnancy
Well
decision support techniques
pump, nos
Doxorubicin/Semustine/Streptozocin Regimen
Child Individual
Never Smoker
macrophage activation syndrome
1+ Score, WHO
Thought Score 1
1+ Score
One
drug, nos
indexing
Abstracting and Indexing
Symptoms Extent Score 1
meconium aspiration syndrome
nursemaid
Child Relation
CDISC SDTM Model Version 1.6

---
https://www.reseau-naissance.fr/medias/2016/12/Anesthesie-chez-parturiente-obese-severe-PRO_012-RSN.pdf
2024
France
guideline
Delivery of Placenta
morbidity
parturition
Borg Category-Ratio 10 Perceived Exertion Score 5
anesthesia
Severe Hallucination
Water Delivery
lack of sensation
obesity
Severe Dysplasia
FBXW4 wt Allele
Intensity and Distress 5
Delivery
Epidermal cGVHD Score 4
Severe Extremity Pain
Anesthesia Procedure
parturition, nos
Obese
Transfer
Birth
Severe Adverse Event
Benzocaine
severe

---
https://publications.msss.gouv.qc.ca/msss/document-003722/
2024
Canada
guideline
manuals as topic
Supper
Mount Device
support, nos
Urgency
Emergency
Emergency Medical Dispatcher
Textbook
Emergency Room

---
https://www.rp2s.fr/wp-content/uploads/2024_Diabete-gestationnel_VDef.pdf
https://www.rp2s.fr/wp-content/uploads/2024_DG_Annexe1_Depistage.pdf
https://www.rp2s.fr/wp-content/uploads/2024_DG_Annexe2_Grossesse.pdf
https://www.rp2s.fr/wp-content/uploads/2024_DG_Annexe3_Accouchement.pdf
2024
France
guideline
Cancer Screening
screening
patient care management
Gestational Diabetes
mass screening
Substance Screening
Genetic Screening
Last Screening
Site Screening
Screening Study
diabetes, gestational
Trial Screening
screening for diabetes
Charge
Eligibility Determination
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening

---
https://pgtm.qc.ca/wp-content/uploads/2024/05/mic_opioides-pediatrie_20240330_final.pdf
2024
Canada
guideline
Pediatric Surgery
general surgery
Departure
Microinvasive Breast Carcinoma
microbial sensitivity tests
April
prescriptions
operative procedure, nos
methyl isocyanate
Leave from Employment
pediatrician
patients
opiate agonist, nos
pediatric surgery
Description
Identifier
Analyzed
Opioid
Pediatricians
hospitals, university
pediatrics
quebec
opioids
Analysis
analgesics, opioid

---
https://www.rheuma-net.ch/fr/doc/acide-mycophenolique/viewdocument/345
2024
Switzerland
guideline
mycophenolic acid
Mycophenolic Acid
Background Treatment
acid, nos

---
https://www.rheuma-net.ch/fr/doc/anti-malariques-f/viewdocument/346
2024
Switzerland
guideline
Background Treatment
antimalarials

---
https://www.rheuma-net.ch/fr/doc/azathioprine-f/viewdocument/347
2024
Switzerland
guideline
Background Treatment
azathioprine
Azathioprine
azathioprine

---
https://www.rheuma-net.ch/fr/doc/cyclophosphamid-1/viewdocument/348
2024
Switzerland
guideline
cyclophosphamide
cyclophosphamide
Background Treatment
Cyclophosphamide

---
https://www.rheuma-net.ch/fr/doc/leflunomid-1/viewdocument/351
2024
Switzerland
guideline
Background Treatment
Leflunomide
Leflunomide

---
https://www.rheuma-net.ch/fr/doc/methotrexat-1/viewdocument/352
2024
Switzerland
guideline
methotrexate
Methotrexate
methotrexate
Background Treatment

---
https://www.rheuma-net.ch/fr/doc/sulfasalazine/viewdocument/353
2024
Switzerland
guideline
Sulfasalazine
sulfasalazine
sulfasalazine
Background Treatment

---
https://www.rheuma-net.ch/fr/doc/apremilast-f/viewdocument/354
2024
Switzerland
guideline
Background Treatment
apremilast
apremilast
Apremilast, (+/-)-
Apremilast

---
https://www.rheuma-net.ch/fr/doc/inhibiteurs-des-janus-kinases-jakinhibs/viewdocument/355
2024
Switzerland
guideline
Janus Kinase Inhibitors
Janus Kinase Family
Background Treatment

---
https://www.rheuma-net.ch/fr/doc/abatacept-2/viewdocument/356
2024
Switzerland
guideline
Abatacept
abatacept
Abatacept
Background Treatment

---
https://www.rheuma-net.ch/fr/doc/anifrolumab-03-2024-f/viewdocument/571
2024
Switzerland
guideline
anifrolumab
Background Treatment
anifrolumab
Anifrolumab

---
https://www.rheuma-net.ch/fr/doc/anti-interleukine-1-f/viewdocument/499
2024
Switzerland
guideline
Thought Score 1
Interleukin-1
Tumor Regression Score 1
Never Smoker
Intensity and Distress 1
1+ Score, WHO
One
ECOG Performance Status 1
Interleukin
CDISC SDTM Model Version 1.6
Illness Intrusiveness Rating 1
One Hundred Percent
Severity of Symptom Score 1
Background Treatment
Clinical Status Ordinal Scale Outcome 1
Upset Score 1
Israel
Mild Adverse Event
Symptoms Extent Score 1
One Full Term Pregnancy
Illinois
Phase I Trial
Neck Pain Score 1
CDISC SDTM Model Version 1.5
Gleason Grade Group 1
1+ Score
Fear Score 1
Agreement Score 1

---
https://www.rheuma-net.ch/fr/doc/anti-il-17-f/viewdocument/416
2024
Switzerland
guideline
Illinois
Interleukin-17
Seventeen
Background Treatment
Interleukin
Israel
UGT1A7 wt Allele

---
https://www.rheuma-net.ch/fr/doc/anti-il-23-f/viewdocument/498
2024
Switzerland
guideline
Interleukin-23
Interleukin
Background Treatment
Illinois
Israel
Phase II/III Trial
Twenty Three

---
https://www.rheuma-net.ch/fr/doc/anti-il-6/viewdocument/360
2024
Switzerland
guideline
Interleukin-6 Inhibitors
Illinois
Fear Score 6
Clinical Status Ordinal Scale Outcome 6
Six
Smoking at Diagnosis
Illness Intrusiveness Rating 6
Interleukin
Severity of Symptom Score 6
Thought Score 6
Background Treatment
Israel

---
https://www.rheuma-net.ch/fr/doc/anti-tnf/viewdocument/357
2024
Switzerland
guideline
Tumor Necrosis Factor Inhibitors
anti-TNF
Anti-Tumor Necrosis Factor Therapy
Background Treatment
tumor necrosis factor

---
https://www.rheuma-net.ch/fr/doc/belimumab-1/viewdocument/358
2024
Switzerland
guideline
belimumab
Belimumab
belimumab
Background Treatment
belimumab

---
https://www.rheuma-net.ch/fr/doc/mepolizumab/viewdocument/572
2024
Switzerland
guideline
mepolizumab
mepolizumab
Mepolizumab
Background Treatment

---
https://www.rheuma-net.ch/fr/doc/rituximab-2/viewdocument/359
2024
Switzerland
guideline
rituximab
Rituximab
Rituximab
Background Treatment

---
https://www.rheuma-net.ch/fr/doc/colchicine/viewdocument/491
2024
Switzerland
guideline
Background Treatment
colchicine
colchicine
Colchicine

---
https://www.rheuma-net.ch/fr/doc/nintedanib-2/viewdocument/510
2024
Switzerland
guideline
nintedanib
nintedanib
Nintedanib
Background Treatment

---
https://www.rheuma-net.ch/fr/doc/recommendations-injections-de-l-appareil-moteur-04-2023-f/viewdocument/365
2024
Switzerland
guideline
Apparatus
injection, nos
health planning guidelines
injections
device, nos
Motor
Inject
Parenteral Dosage Form
Motor Device
equipment and supplies

---
https://www.rheuma-net.ch/fr/doc/recommandations-traitement-antirhumatismal-pendant-la-grossesse/viewdocument/364
2024
Switzerland
guideline
Pregnant
Therapy Object
lactation
health planning guidelines
Treat
Pregnancy
Treatment Epoch
During Treatment
Biomaterial Treatment
Lactating
Management
Treatment Study
Management Occupations
lactation, nos
On Treatment
GDC Treatment Frequency Terminology
pregnancy, nos
Treatment
pregnancy
No Treatment for Diabetes

---
https://www.rheuma-net.ch/fr/doc/recommandations-pour-la-gestion-perioperatoire-du-traitement-de-fond/viewdocument/362
2024
Switzerland
guideline
health planning guidelines
Perioperative
Management Occupations
Management
Background Treatment

---
https://ansm.sante.fr/actualites/decision-du-28-05-2024-fixant-les-regles-auxquelles-se-conforment-les-ersa-pour-effectuer-le-deconditionnement-et-le-reconditionnement-des-specialites-pharmaceutiques-beneficiant-dune-amm-prevue-a-larticle-l-5121-8-du-csp
2024
false
false
false
France
French
guidelines for drug use
guideline
legislation
legislation, pharmacy
Military Health Services
product packaging

---
https://www.afsos.org/wp-content/uploads/2024/03/CANCER-ET-SOMMEIL-version-finale-03-24.pdf
2024
France
guideline
sleep, nos
cancer
Malignant Neoplasm
Hour Of Sleep
neoplasms
sleep
neoplasm, malignant
Sleep
EPO wt Allele

---
https://www.has-sante.fr/jcms/p_3293982/fr/bonnes-pratiques-professionnelles-des-prestataires-de-services-et-distributeurs-de-materiel-psdm
2024
France
guideline
Supplier
Software Service
Department
Best Practice
professional practice
Handbook
PRETEXT Stage 1
PRETEXT Stage 4
Professional Practice
Provider
best practices
PRETEXT Stage 3
PRETEXT Stage 2
Guide Device
methods

---
https://publications.msss.gouv.qc.ca/msss/document-003757/
2024
Canada
guideline
Kit Dosage Form
Human Cells, Tissues, and Cellular and Tissue-Based Products Packing
CDISC ADAS-Cog - Orientation Summary Score
Montreal Cognitive Assessment Orientation Test
Drug Kit
Direction
transposition of great vessels
Mast/Stem Cell Growth Factor Receptor Kit
Referral
Thoracic Gas Volume
Check
Orientation
Overall
Verification
orientation
Certification
Referring
auditor
certification
Package
Package Dosing Unit
orientation, nos
KIT wt Allele
Oncogene KIT
Kit Dosing Unit

---
https://conseil-scientifique.public.lu/fr/publications/risques-vasculaires/role-des-premiers-intervenants-dans-la-prise-en-charge-d-un-patient-adulte-en-arret-cardio-respiratoire-non-traumatique-en-dehors-de-l-hopital-version-longue.html
https://conseil-scientifique.public.lu/fr/publications/risques-vasculaires/role-des-premiers-intervenants-dans-la-prise-en-charge-d-un-patient-adulte-en-arret-cardio-respiratoire-non-traumatique-en-dehors-de-l-hopital-arbre-decisionnel.html
2024
Luxembourg
guideline
algorithms
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
RET Rearrangement Analysis Was Not Performed
Use of Smokeless Tobacco at Time of Diagnosis Negative
Caffeine Not Routinely Consumed
ATRX Gene Mutation Negative
Medication Not Taken
ATRX Mutation Analysis Was Not Performed
wounds and injuries
Adjuvant Post-operative Radiation Therapy Was Not Administered
Local Anesthesia Agents were not Administered
Evidence of Disease Absent after Completion of Therapy
Patient was Not Previously Evaluated for Current Chief Complaint
Tumor Reoccurrence Absent After Initial Treatment
Another Form of Birth Control was not Used
No History of Gestational Complication
No History of Kawasaki Disease
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
BRAF Rearrangement Analysis Was Not Performed
Preoperative IV Antiemetics were not Administered
Nitric Oxide Measurement
SDH Complex Mutation Analysis Was Not Performed
IV Anesthesia was not Administered
Adjuvant Post-operative Immunological Therapy Was Not Administered
No History of Congenital Heart Disease
No History of Non-Cardiac Surgery
Paraneoplastic Syndrome is Not Present
Negation
Cancer History Absent
Norway
Regular Smokeless Tobacco Use for Six Weeks or More Negative
Legal Adult
Patient was not Postmenopausal with no Prior Oophorectomy
First Degree Family History of Primary Brain Tumor Negative
NF1 Mutation Analysis Was Not Performed
case management
Role Entity
ERBB2 Mutation Analysis Was Not Performed
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
First Degree Family History Thyroid Cancer Negative
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
New Disease is not Multifocal
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
PTEN Mutation Analysis Was Not Performed
Intervention Not Given for Kawasaki Disease
Regional Anesthesia was not Administered
MGMT Promoter Methylation Testing Was Not Performed
Neither Case or Control Status
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
MET Mutation Analysis Was Not Performed
Intercurrent Illness is Absent at Onset of Chief Complaint
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Family History of Stomach Cancer Absent
Physician Diagnosed Diabetes Absent
KRAS Mutation Analysis Was Not Performed
Additional Surgery for New Tumor Event Absent
EGFR Amplification Analysis Was Not Performed
10q23/PTEN Locus Deletion Analysis Was Not Performed
1p/19q Deletion Analysis Was Not Performed
Other Preoperative IV Medications were not Administered
Respiratory Arrest
Lymph Node Dissection Was Not Performed
Unemployed
Social Role
Chief Complaint was Not Witnessed
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
adult
Neither
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Routine Cytogenetics Were not Completed
No History of Myopathy
No Known History of Illicit Drug Use
History of Colorectal Cancer Negative
Preoperative IV Antacids were not Administered
EGFR Gene Amplification Negative
First Degree Family History Cancer Negative
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
No Response to Intervention for Kawasaki Disease
Adjuvant Post-operative Chemotherapy Was Not Administered
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Not Lost to Follow-Up
Nitric Oxide
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Minor Criteria for Rheumatic Heart Disease Not Present
Patient Load
Chemotherapy Not Received
Additional Immunohistochemistry Was Not Performed
EGFR Mutation Analysis Was Not Performed
Security Role Object
NON Mouse
History of Medical Treatment Absent
IDH Family Wildtype
Injury
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
Preoperative IV Sedation was Not Administered
KIT Mutation Analysis Was Not Performed
No Known History of Alcohol Use
Chief Complaint Not Caused by Trauma
Any Metastatic Diagnosis Absent
has patient
NCI Thesaurus Role
IDH Family Mutation Analysis Was Not Performed
Adjuvant I-131 Therapy Negative
Has No Sibling
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
No History of Rheumatic Fever
hospitals
PDGFRA Mutation Analysis Was Not Performed
Fluorescence In Situ Hybridization Was Not Performed
ALK Rearrangement Analysis Was Not Performed
Additional Molecular Studies Were Not Performed
adulthood
No History of Neonatal Complication
hospital, nos
ROS1 Rearrangement Analysis Was Not Performed
injury, nos
PTEN Gene Mutation Negative
Preoperative IV Opiates were not Administered
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Documentation Absent
role
TP53 Mutation Analysis Was Not Performed
Therapeutic Ionizing Radiation to Head History Absent
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
respiratory arrest
NRAS Mutation Analysis Was Not Performed
Tumor Progression Absent After Initial Treatment
Chemical/Occupational Exposure Absent
New Tumor Event After Initial Treatment Absent
BRAF Mutation Analysis Was Not Performed
Radiation Therapy Not Received
Radiation History Negative
Hypertension Absent

---
https://www.rp2s.fr/wp-content/uploads/2024_Protocole_transfert_pour_embolisation.pdf
2024
France
guideline
Transfer Ability
Embolization Therapy
Murine Breast
Female Breast
Maternal Relative
Male Breast
Transference
Transfer
mother, nos
Countertransference
Transfer, Psychology
breast
Maternal

---
https://www.cancer.fr/catalogue-des-publications/unites-de-coordination-en-oncogeriatrie-organisation-et-missions
2024
false
false
false
France
guideline
organizers, embryonic
Religious Missions
Organizational Unit
Coordination
coordination, nos
organization

---
https://www.rp2s.fr/wp-content/uploads/2024_SulfateMagnesium.pdf
2024
France
guideline
fetus
Magnesium Sulfate
Obstetrics
fetus, nos
indication of
indicators and reagents
suggestive of
magnesium sulfate
Fetus
Petal
magnesium sulfate

---
https://www.sfed.org/wp-content/uploads/2024/07/RecoSFED-GIFE-personnelparamedical-au-sein-dun-plateau-technique-endo-digestive-24.pdf
2024
France
guideline
digestive tract function, nos
breast
Tray
endoscopy, digestive system
health planning guidelines
Female Breast
Digestion
paramedics
Paramedic
Endoscopic Procedure
allied health personnel
endoscopy of breast, nos
digestant, nos
Male Breast
Murine Breast

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/utilisation-judicieuse-des-hemocultures.html
2024
Canada
guideline
Use
Blood Culture
blood culture, nos

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/diminuer-lempreinte-carbone-des-agents-anesthesiques-inhales-au-bloc-operatoire-lors-dune-anesthesie-generale-strategies-et-enjeux-a-considerer.html
2024
Canada
guideline
Reduced
Inhaler
anesthesia, inhalation
anesthesia, general
Carbon
Inhalation Dosing Unit
operating rooms
Operating Room
operative block anesthesia
carbon, nos
Inhalation
Strategy
Inspiration
Inhalation Route of Administration
general anesthesia, nos
Decreased
General Anesthesia Procedure
Inhalation Method of Administration
general inhalation anesthetic, nos
Inhale
anesthetics, inhalation
carbon footprint
temefos
Anesthetic Agent

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/initier-un-examen-dosteodensitometrie-a-la-suite-de-levaluation-du-risque-fracturaire-avec-loutil-frax.html
2024
Canada
guideline
Scientific Equipment
Tool
Review
tool, nos
Health Risk Assessment
risk assessment
Medical Examination
Examination
Initiation

---
https://www.ordre.pharmacien.fr/les-communications/focus-sur/les-autres-publications/recommandations-ordinales-prescription-et-dispensation-des-traitements-de-substitution-aux-opiaces
2024
France
guideline
Biomaterial Treatment
Prescription
Trait
Ordinal Scale
Ordinal Position
Therapy Object
Treat
On Treatment
opiate substitution treatment
Treatment Study
Tray Dosing Unit
Treating
Opiate
GDC Treatment Frequency Terminology
Dispensing
prescription, nos
Off-Label use
Treatment Epoch
No Treatment for Diabetes
Tray
During Treatment
Substitution
Treatment
Missense Mutation
Under No Medication

---
https://ansm.sante.fr/actualites/publication-et-entree-en-vigueur-de-lannexe-1-des-bonnes-pratiques-de-fabrication-des-medicaments-steriles
2024
false
false
false
France
French
drug information
guideline
pharmaceutical preparations

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/traitement-intravesical-du-cancer-de-la-vessie.html
2024
Canada
technical report
review of literature
guideline
weights and measures
musculoskeletal rotation, nos
Preventive
Bacillus Calmette-Guerin Antigen
measures
Childhood Bladder Carcinoma
patients
preventive treatment, nos
Epidermolytic Ichthyosis
Patient Reported Outcome Measures
has patient
malignant neoplasm of bladder
BCG
KRT10 wt Allele
Cancer Therapeutic Procedure
BCG
Intravesical
Intravesical Route of Administration
rotation
BCG Vaccine
BCG
urinary bladder cavity
People
urinary bladder cancer
neoplasm, malignant
mycobacterium bovis
persons
Clinical Outcomes Assessment Context of Use
Patient
immunocompromised host
urinary bladder neoplasms
Bladder Cancer Pathway

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/trouble-depressif-caracterise-pendant-la-grossesse.html
2024
Canada
technical report
review of literature
guideline
Ratio
depressive disorder
pregnancy, nos
depressive disorder, nos
research report
Scientific Equipment
operations research
Depression
tool, nos
Regulatory Report
Pregnancy
No Support Needed
depressive disorder
Tool
Decision Aid
Support
Characterization
albumin/globulin ratio
Pregnant
pregnancy

---
https://www.reseau-naissance.fr/medias/2024/07/RSN-supplementation-vit-D-et-PEC-hypoca-2024.pdf
2024
France
guideline
Date of Diagnosis
health planning guidelines
Charge
diagnosis
hospitals, maternity
Diagnosis Code
Disease or Disorder
Newar Language
vitamin D
motherhood
no diagnosis
patient care management
Vitamin D Measurement
Hypocalcemia
Ergocalciferol
infant, newborn
hypocalcemia
newborn, nos
Nutritional Supplementation
hypocalcemia
New Lesion Identification
Diagnosis Study
vitamin d, nos
Human Papillomavirus-35
Thirty Five

---
https://www.has-sante.fr/jcms/p_3445779/fr/lieux-et-conditions-d-environnement-pour-la-realisation-d-une-teleconsultation-ou-d-un-telesoin-recommandations
2024
false
false
false
France
guideline
achievement
Approximate
telemedicine
Surrounding
environment
health planning guidelines
remote consultation
Environmental
telenursing
teleconsultation

---
https://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Medicaments/INESSS_Nitroglycerine_RR.pdf
2024
false
false
false
Canada
guideline
Pet Responds to Presence
Response_Gloss
Fasting Status Indicator
nitroglycerin
sublingual gland
Nitroglycerin
tablets
Spray
Uruguay
Responsive Disease
Fasting
Rapidly
nitroglycerin
Sublingual Tablet Dosage Form
Strategy
Aerosolize
FASTK wt Allele

---
https://www.has-sante.fr/jcms/p_3383435/fr/cephalees-de-l-enfant-et-l-adolescent-pertinence-de-l-imagerie
2024
France
guideline
headache, nos
Imaging Device
adolescence
headache disorders
Professional Practice
Enhance
PHQ-15 - Headaches
PHQ Screener Version - Headaches
child, nos
Child Individual
child
Adolescent
Child Relation
tool, nos
Get Headaches
adolescent
Headache
professional practice
Adolescents
Teenager
Improved

---
https://has-sante.fr/jcms/p_3491702/fr/l-accompagnement-vers-et-dans-l-habitat-par-les-professionnels-des-essms-volet-1-socle-transversal
2024
France
guideline
Volt
One Hundred Percent
Left Arm
Fear Score 1
Severity of Symptom Score 1
Volar
One Full Term Pregnancy
Illness Intrusiveness Rating 1
Poultice
Poultice Dosage Form Category
actor
One
Neck Pain Score 1
1+ Score
Mild Adverse Event
Ethiopia
Never Smoker
Phase I Trial
Tumor Regression Score 1
Intensity and Distress 1
Endotracheal Route of Administration
Clinical Status Ordinal Scale Outcome 1
1+ Score, WHO
ECOG Performance Status 1
Symptoms Extent Score 1
Agreement Score 1
CDISC SDTM Model Version 1.6
Lupus Anticoagulant Antibody
ecosystem
CDISC SDTM Model Version 1.5
Andorra
Lanthanum
SSB wt Allele
Cross-Sectional Study
Docetaxel/Epirubicin Regimen
entrance
Gleason Grade Group 1
transverse
Louisiana
Lao People's Democratic Republic
Upset Score 1
habitat
Essential Thrombocythemia
Thought Score 1

---
https://www.reseau-naissance.fr/medias/2024/01/RSN-PRO_004-PEC-alcoolisation-aigue-pendant-la-grossesse-Situation-de-dependance.pdf
2024
France
guideline
algorithms
pregnancy
Pregnancy
Ethanol Ablation Therapy
Pregnant
acute alcohol abuse
patient care management
Charge
pregnancy, nos

---
https://www.canada.ca/fr/sante-publique/services/maladies-infectieuses/sante-sexuelle-infections-transmissibles-sexuellement/lignes-directrices-canadiennes/verrues-anogenitales.html
2024
Canada
guideline
LATS1 wt Allele
warts
papillomaviridae
warts
condylomata acuminata
Human Papillomavirus Viruses
KMT2A wt Allele
human papillomavirus, nos
condyloma acuminatum
Human Papillomavirus

---
https://www.canada.ca/fr/sante-publique/services/maladies-infectieuses/sante-sexuelle-infections-transmissibles-sexuellement/lignes-directrices-canadiennes/syphilis.html
2024
Canada
guideline
Information Resource
Resource Guide
information resources
syphilis
health resources
Importer
Guide Device
source guides
Syphilis
Import
syphilis, nos

---
https://www.canada.ca/fr/sante-publique/services/vih-sida/guide-depistage-diagnostic-infection-vih.html
2024
Canada
guideline
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
Substance Screening
HIV Infection
viruses
hiv infections
Cancer Screening
no diagnosis
mass screening
HIV Infection Diagnosis
human immunodeficiency virus infection, nos
HIV
screening
Screening Study
Last Screening
humans
Guide Device
Human Immunodeficiency Virus
Eligibility Determination
human immunodeficiency virus, nos
Handbook
Genetic Screening
Date of Diagnosis
Diagnosis Study
Trial Screening
Site Screening
Diagnosis Code

---
https://www.canada.ca/fr/sante-publique/services/maladies-infectieuses/sante-sexuelle-infections-transmissibles-sexuellement/lignes-directrices-canadiennes/guide-prevention-itss.html
2024
Canada
guideline
public health guidelines
Blood Sample
Prevention Study
Guide Device
infectious disease, nos
Prevention
Murine Blood
Sexually Transmitted Disorder
Preventive Intervention
Handbook
Blood
infection control
blood
sexually transmitted diseases

---
https://www.reseau-naissance.fr/medias/2024/02/Pratique-du-blood-patch-en-obstetrique-RSN-PRO-007-.pdf
2024
France
guideline
Extended Release Patch Dosage Form
Patch
obstetrics
Patch Dosing Unit
Observational Study Sampling Method
Splayed
transdermal patch

---
https://www.reseau-naissance.fr/medias/2024/02/Utilisation-cell-saver-en-obstetrique-PRO-006-RSN.pdf
2024
France
guideline
Use
obstetrics
Observational Study Sampling Method

---
https://ansm.sante.fr/tableau-marr/aciclovir
2024
false
false
false
France
French
guideline
patients guideline
drug information
risk management
acyclovir
Accidental Drug Ingestion
Muco-adhesive Buccal Tablet Dosage Form

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/expression-des-volontes-au-regard-des-objectifs-de-soins-et-de-la-decision-relative-a-la-reanimation-cardiorespiratoire.html
2024
Canada
guideline
resuscitation orders
volition
cardiopulmonary resuscitation
Resuscitation
How True Feel Carefree Right Now
resuscitation decisions
critical care
Care
Phrases
Healthcare
Reasoning
goals
Abnormal Involuntary Movement Scale Clinical Classification
Gene Expression
volition, nos
Healthcare Activity

---
https://ansm.sante.fr/actualites/difficultes-dapprovisionnement-en-rythmodan-250-mg-lp-ce-medicament-doit-etre-remplace-par-rythmodan-100-mg
2024
false
false
false
France
French
guideline
drug information
disopyramide
Disopyramide Phosphate
administration, oral
anti-arrhythmia agents
patient education handout

---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1369
2024
France
guideline
Neither Agree or Disagree
usutu virus
Virus
simian immunodeficiency virus
homo sapiens
risk
judgment
humans
Disease Transmission
Usutu virus
bone screws
Supplies
Usutu virus
Human Origin

---
https://www.infectiologie.com/fr/actualites/vaccination-antimeningococcique-des-adolescents_-n.html
2024
France
guideline
Reminder
vaccination
neisseria meningitidis
adolescence
france
vaccination, nos
Callback
Adolescents
vaccinia, nos
Illinois
meningococcal infections
classification
vaccine, nos
infectious disease, nos
adolescent
Infection
Conjugate Vaccine
System User
french
vaccines, conjugate
Recollect
What Month is it
Use
Booster
Teenager
CHFR Gene
adult children
adulthood
Interleukin
Israel
young adult
Invasion
Adolescent
preventive immunization/medication
Young Adult

---
https://www.has-sante.fr/jcms/p_3497216/fr/labellisation-par-la-has-d-un-flash-securite-patient-elabore-par-un-organisme-externe
2024
France
guideline
Scientific Equipment
outpatients
Professional Practice
organ part
tool, nos
professional practice
Outpatient
Safety
organizations
Improved
CASP8AP2 wt Allele
Whole Organism
patient safety
Tool
Enhance
Organism Part
societies
has patient
Labeled
Safety Study

---
https://www.sfmu.org/upload/consensus/RFE2024_Anticoagulation_contexte_urgence.pdf
2024
France
guideline
health planning guidelines
anticoagulant, nos
emergencies
anticoagulants

---
https://www.sfmu.org/upload/consensus/RPP2024_prevention_antithrombotique_urgence.pdf
2024
France
guideline
health planning guidelines
fibrinolytic agents
antithrombotic agents
emergencies

---
https://ansm.sante.fr/documents/reference/bonnes-pratiques-de-fabrication-de-medicaments-a-usage-humain
2024
false
France
French
pharmaceutical preparations
legislation, pharmacy
drug industry
drug industry
technology, pharmaceutical
drug compounding
quality control
europe
guideline
france

---
https://ansm.sante.fr/actualites/ballons-gastriques-allurion-recommandations-pour-limiter-la-survenue-de-complications-graves
2024
false
false
false
France
French
equipment and supplies note
gastric balloon
continuity of patient care
Insertion of gastric balloon (procedure)
guideline
patients guideline
intestinal obstruction
Acquired obstruction of pylorus (disorder)
Pyloric Obstruction
Gastric Perforation
risk
risk management

---
https://ansm.sante.fr/actualites/tensions-dapprovisionnement-en-stylo-dadrenaline-anapen-recommandations-et-disponibilites-des-autres-stylos
2024
false
false
false
France
French
epinephrine
france
Epinephrine autoinjector (physical object)
drug information
epinephrine
guideline

---
https://ansm.sante.fr/actualites/lansm-suspend-les-ballons-gastriques-allurion
2024
false
false
false
France
French
equipment and supplies note
guideline
gastric balloon
Safety-Based medical device withdrawals
france

---
https://ansm.sante.fr/dossiers-thematiques/topiramate-et-grossesse
2024
false
false
false
France
French
Topiramate
pregnancy
patients guideline
epilepsy
migraine disorders
Topiramate
guideline
risk
abnormalities, drug-induced
In Utero Drug Exposure
Female of Childbearing Potential
topiramate

---
https://www.cbip.be/fr/articles/4360?folia=4353
2024
false
false
false
Belgium
French
measles
belgium
journal article
measles
vaccination
measles vaccine
guideline

---
https://ansm.sante.fr/informations-de-securite/suspension-des-autorisations-de-mise-sur-le-marche-des-medicaments-contenant-du-caproate-dhydroxyprogesterone
2024
false
false
false
France
French
pharmacovigilance note
Safety-Based drug withdrawals
17 alpha-Hydroxyprogesterone Caproate
injections, intramuscular
Delayed-Action preparations
progestins
hydroxyprogesterone
neoplasms
prenatal exposure delayed effects
In Utero Drug Exposure
guideline

---
https://www.has-sante.fr/jcms/p_3534978/fr/prise-en-charge-chirurgicale-des-tendinopathies-rompues-de-la-coiffe-des-rotateurs-chez-l-adulte-note-de-cadrage
2024
France
guideline
Rotator Cuff
Improved
Charge
Tool
adulthood
Professional Practice
tool, nos
laceration, nos
adult
Notable
Footnote
rotator cuff
Hibiscus sabdariffa Flower
Legal Adult
Scientific Equipment
Trifolium pratense Flower
patient care management
tendinopathy
professional practice
Enhance
Tiaprofenic Acid

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/protocole-medical-national-ajustement-de-la-medication-antidiabetique-dans-le-diabete-de-type-2.html
2024
Canada
guideline
diabetes non-insulin dependent
Type 2 Diabetes Mellitus
drug, nos
diabetes mellitus, type 2
drug therapy
Fecal Immunochemical Test
hypoglycemic agents
Adjustment
Coping
adjustment, nos
Anti-diabetic Agent
Clinical Study Protocol
Under No Medication
On Study
antidiabetics

---
https://www.sfed.org/actualites/dernieres-recommandations-de-lesge-sur-la-prise-en-charge-de-loesophage-de-barrett-les-points-clefs/
2024
France
guideline
french abstract
Point Name
barrett esophagus
barrett's esophagus
patient care management
TIP GCT Study Identifier
Last
KAT5 wt Allele
Charge
Point
health planning guidelines
Barrett Esophagus
TIP Regimen
Tip

---
https://www.sggg.ch/fileadmin/user_upload/Dokumente/3_Fachinformationen/1_Expertenbriefe/Fr/84_Examen_urodynamique.pdf
2024
Switzerland
guideline
N
Newton
Medical Examination
No
Review
N Category
MATCH Arm EAY131-N
Tumor to Normal
Neither Agree or Disagree
Signal to Noise Ratio
expert opinion
Nano
urodynamics
Examination
expert testimony

---
https://www.sggg.ch/fileadmin/user_upload/Dokumente/3_Fachinformationen/1_Expertenbriefe/Fr/85_Traitement_de_l_incontinence_d_effort_-_injection_transuretrale_d_agents_de_comblement.pdf
2024
Switzerland
guideline
Under No Medication
expert testimony
During Treatment
Treatment
On Treatment
Tumor to Normal
Signal to Noise Ratio
N
N Category
No Treatment for Diabetes
Neither Agree or Disagree
Effort
GDC Treatment Frequency Terminology
expert opinion
incontinence, nos
No Effort
Biomaterial Treatment
Treat
exercise therapy
No
MATCH Arm EAY131-N
Treatment Epoch
exertion, nos
Newton
Therapy Object
Treatment Study
Incontinence
Nano

---
https://www.sggg.ch/fileadmin/user_upload/Dokumente/3_Fachinformationen/1_Expertenbriefe/Fr/EB_87_Stockage_de_cellules_souches_de_sang_de_cordon_ombilical_public.pdf
2024
Switzerland
guideline
Nano
Public
cord blood
MATCH Arm EAY131-N
No
Umbilical Cord Blood
N
stem cell
Stem Cell
fetal blood
stem cells
Neither Agree or Disagree
Murine Stem Cells
Newton
cord blood
Hoarding
Storage
expert testimony
expert opinion
N Category
Tumor to Normal
umbilical cord
Signal to Noise Ratio
blood cells

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/indications-cliniques-de-la-protontherapie-en-oncologie.html
2024
false
false
false
Canada
child
neoplasms
radiation oncology
guideline
medical oncology
proton therapy
Clinical Oncology
Proton Beam Radiation Therapy

---
https://ansm.sante.fr/actualites/difficultes-dapprovisionnement-en-praluent-300-mg-les-pharmaciens-peuvent-dispenser-une-boite-de-deux-stylos-preremplis-praluent-150-mg-en-remplacement-de-praluent-300-mg
2024
false
false
false
France
French
drug information
alirocumab
continuity of patient care
france
guideline
pharmacists
alirocumab
patient education handout

---
https://www.asn.fr/l-asn-informe/actualites/mammographie-recommandations-du-gprp-et-prise-de-position-de-l-asn
2024
France
guideline
CDISC SDTM Body Position Terminology
GPX2 wt Allele
Position
mammography
health planning guidelines
Gene Physical Location
Asparagine Measurement
Mammography
Asparagine
mammography, nos

---
https://www.reseau-naissance.fr/wp-content/plugins/creasit-base-documentaire/telechargement.php?doc=11668
2024
false
false
false
France
hemostatic disorders
anesthesia, epidural
parturition
pregnancy
midwifery
guideline

---
https://www.icn.ch/sites/default/files/2024-09/PHC%20position%20statement_FR.pdf
2024
Switzerland
guideline
primary health care
principal
primary health care

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/ajustement-des-antidepresseurs-pour-le-suivi-dun-trouble-depressif-caracterise-majeur-ou-dun-trouble-anxieux.html
2024
false
false
false
Canada
depressive disorder, major
anxiety disorders
antidepressive agents
panic disorder
adult
antidepressive agents
Healthy Lifestyle
technical report
guideline

---
https://ansm.sante.fr/actualites/analogues-du-glp-1-et-diabete-de-type-2-reprise-progressive-des-initiations-de-traitement-pour-ozempic-et-victoza
2024
false
false
false
France
French
patient education handout
guideline
drug information
Glucagon-Like Peptide-1 Receptor Agonists
diabetes mellitus, type 2
Glucagon-like peptide-1 (GLP-1) analogues
Pharmacotherapy Initiation
Pharmacotherapy Continuation
dulaglutide
semaglutide
Liraglutide

---
https://www.inspq.qc.ca/publications/3537
2024
Canada
guideline
effects of exposure to external cause, nos
bruit
Handbook
noise
weights and measures
occupational exposure
Exhibition
De-Identification
measures

---
https://www.sfndt.org/sites/www.sfndt.org/files/medias/documents/ipna%20_2024_fiche_info_SNCS.pdf
2024
false
false
false
France
nephrotic syndrome
immunosuppressive agents
Calcineurin Inhibitors
cyclophosphamide
levamisole
mycophenolic acid
Healthy Lifestyle
guideline
french abstract
child
nephrotic syndrome

---
https://ansm.sante.fr/actualites/avis-de-lansm-en-date-du-10-09-2024-sur-les-conditions-de-mise-en-oeuvre-de-la-substitution-au-sein-des-groupes-biologiques-similaires-ranibizumab-et-aflibercept
2024
false
false
false
France
French
biosimilar pharmaceuticals
drug substitution
Ranibizumab
drug information
guideline
aflibercept
legislation, pharmacy

---
https://www.afsos.org/wp-content/uploads/2024/09/AFSOS-referentiel-NVAI_0824.pdf
2024
false
false
false
France
antineoplastic agents
chemotherapy-induced nausea and vomiting
antiemetics
algorithms
nausea
guideline

---
https://ansm.sante.fr/actualites/vitamine-b12-injectable-et-buvable-preferez-les-comprimes-aux-ampoules-pour-lusage-par-voie-orale
2024
false
false
false
France
French
drug information
guideline
injections, intramuscular
administration, oral
vitamin B 12
Malabsorption of Vitamin B12
vitamin b 12 deficiency
cyanocobalamin
-
-

---
https://www.ameli.fr/pharmacien/actualites/verifier-et-signaler-une-fausse-ordonnance-avec-asafo-sur-amelipro
2024
false
false
false
France
French
fraud
drug prescriptions
Falsification (finding)
whistleblowing
guideline
pharmacists

---
https://www.health.belgium.be/fr/mpox-guidelines-pour-les-professionnels-de-sante
2024
Belgium
guideline
guideline
health
Mpox, Monkeypox
health personnel

---
https://publications.msss.gouv.qc.ca/msss/document-003743/
2024
Canada
guideline
De-Identification

---
https://www.has-sante.fr/jcms/p_3545041/fr/energies-laser-en-urologie
2024
France
guideline
patient safety
solutions
urology
tool, nos
professional practice
solution, nos
has patient
laser

---
https://ansm.sante.fr/actualites/analogues-du-glp-1-et-obesite-nous-prenons-des-mesures-pour-securiser-leur-utilisation-en-france
2024
false
false
false
France
French
patient safety
Glucagon-Like Peptide-1 Receptor Agonists
obesity
france
Drug Misuse
prescription drug misuse
drug prescriptions
critical pathways
semaglutide
Wegovy
pharmacovigilance note
guideline
Saxenda

---
https://www.has-sante.fr/jcms/p_3551950/fr/criteres-d-orientation-en-readaptation-cardiaque-et-vasculaire
2024
France
guideline
blood vessel, nos
Cardiac Rehabilitation
orientation, nos
post-cardiac rehabilitation training
professional practice
tool, nos
orientation

---
https://ansm.sante.fr/actualites/clarithromycine-recommandations-de-bon-usage-pour-contribuer-a-garantir-la-couverture-des-besoins-des-patients
2024
false
false
false
France
French
guidelines for drug use
clarithromycin
anti-bacterial agents
anti-bacterial agents
clarithromycin
clarithromycin
patients guideline
guideline

---
https://www.acadpharm.org/dos_public/COMMUNIQUE_MALADIES_RENALES_CHRONIQUES_VF.PDF
2024
France
guideline
chronic renal failure syndrome, nos
end-stage
screening
renal insufficiency, chronic
kidney failure, chronic
mass screening
health planning guidelines

---
https://www.has-sante.fr/jcms/p_3549483/fr/bientraitance-et-gestion-des-signaux-de-maltraitance-en-etablissement-mise-en-oeuvre-en-milieu-sanitaire-medico-social-et-social-personnes-majeures
2024
France
guideline
persons
mandatory reporting
cues
Handbook
social environment
social welfare
socialism

---
Nous contacter.
24/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.